Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -13.34 | 13.40 |
| PEG Ratio (TTM) | 0.26 | 6.66 |
| P/S Ratio (TTM) | 1.18 | 6.81 |
| P/B Ratio (TTM) | 1.50 | 32.01 |
| P/FCF Ratio (TTM) | -32.40 | 16.50 |
| Price to 5YR AVG Earnings Ratio | -5.98 | 4.20 |
| Price to 5YR AVG FCF Ratio | -564.43 | 47.01 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -7.61% | 0.15% |
| ROE (TTM) | -11.45% | -139.18% |
| Net Profit Margin (TTM) | -8.50% | 1.19% |
| ROIC 5YR AVG | -13.67% | 28.87% |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -236.75% | 47.04% | 38.77% |
| Revenue | 0.40% | 130.74% | 89.52% |
| Net Income | -244.55% | 13.53% | 16.88% |
| Cash Flow | 107.79% | 2,321.88% | 2,393.63% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.05 | 2.63 |
| Quick Ratio (TTM) | 1.05 | 2.50 |
| D/E Ratio (TTM) | 0.14 | 1.17 |
| Interest Coverage (TTM) | -1.81 | 5.70 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 1.81 | 4.72 |
| LTL to 5YR AVG FCF | -12.00 | 3.13 |
| Shares Outstanding Growth 5YR AVG | 65.30% | 2.03% |